Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Florastamin PET/CT vs MRI in High Risk Prostate Cancer
NCT05004285Phase 3Active, not recruiting
- Sponsor
- FutureChem Co., Ltd.
- Start
- Apr 2021
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of betamethasone + dexchlorpheniramine in prostate cancer (PCa), sponsored by FutureChem Co., Ltd.. Started Apr 2021; status: active, not recruiting.
02
Drugs
betamethasone + dexchlorpheniramine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05004285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05004285.